Molecular genetics and epidemiology of epithelial ovarian cancer (Review)
- PMID: 21922146
- DOI: 10.3892/or.2011.1456
Molecular genetics and epidemiology of epithelial ovarian cancer (Review)
Abstract
This review summarizes data from recent molecular genetic and epidemiology studies of the generic term 'female pelvic cancer'. The English-language literature was reviewed for genetic, epigenetic, epidemiologic and environmental risk factors. There are well-documented disparities among racial and ethnic groups with respect to epithelial ovarian cancer (EOC) prevalence. In the case of the serous histological subtype, primary EOC, fallopian tube cancer and peritoneal cancer could be regarded as a single disease entity. However, EOC is not a single disease. Comparing the profile of EOC between Japanese and Caucasians, clear cell carcinomas (27.6%) are more common in Japan, possibly with fewer serous adenocarcinomas (40.7%). This may reflect a proportional increase. The Japanese may exhibit a higher proportion of malignant transformation of endometriosis compared to the United States population. Although some part of the molecular genetic pathogenesis has been unveiled, the complete events of molecular genetic epidemiological changes associated with EOC remain to be identified. This review focuses on current knowledge of the genetic and environmental factors affecting the development of EOC, and outlines future challenges in its pathogenesis research.
Similar articles
-
An increased risk of epithelial ovarian cancer in Taiwanese women with a new surgico-pathological diagnosis of endometriosis.BMC Cancer. 2014 Nov 18;14:831. doi: 10.1186/1471-2407-14-831. BMC Cancer. 2014. PMID: 25403543 Free PMC article.
-
Endometriosis and the subsequent risk of epithelial ovarian cancer.Taiwan J Obstet Gynecol. 2014 Dec;53(4):530-5. doi: 10.1016/j.tjog.2014.04.025. Taiwan J Obstet Gynecol. 2014. PMID: 25510696
-
Dietary fat intake and ovarian cancer risk: a meta-analysis of epidemiological studies.Oncotarget. 2016 Jun 14;7(24):37390-37406. doi: 10.18632/oncotarget.8940. Oncotarget. 2016. PMID: 27119509 Free PMC article. Review.
-
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk.PLoS One. 2015 Jun 19;10(6):e0128106. doi: 10.1371/journal.pone.0128106. eCollection 2015. PLoS One. 2015. PMID: 26091520 Free PMC article.
-
The molecular genetics of hereditary and sporadic ovarian cancer: implications for the future.Br Med Bull. 2014 Dec;112(1):57-69. doi: 10.1093/bmb/ldu034. Br Med Bull. 2014. PMID: 25473022 Review.
Cited by
-
Comparison of plasma amino acid profile-based index and CA125 in the diagnosis of epithelial ovarian cancers and borderline malignant tumors.Int J Clin Oncol. 2017 Feb;22(1):118-125. doi: 10.1007/s10147-016-1035-4. Epub 2016 Sep 13. Int J Clin Oncol. 2017. PMID: 27623814
-
Comprehensive Serum Glycopeptide Spectra Analysis (CSGSA): A Potential New Tool for Early Detection of Ovarian Cancer.Cancers (Basel). 2019 Apr 27;11(5):591. doi: 10.3390/cancers11050591. Cancers (Basel). 2019. PMID: 31035594 Free PMC article.
-
Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma.PLoS One. 2016 Oct 31;11(10):e0165609. doi: 10.1371/journal.pone.0165609. eCollection 2016. PLoS One. 2016. PMID: 27798689 Free PMC article.
-
Upregulation of MiR-205 transcriptionally suppresses SMAD4 and PTEN and contributes to human ovarian cancer progression.Sci Rep. 2017 Feb 1;7:41330. doi: 10.1038/srep41330. Sci Rep. 2017. PMID: 28145479 Free PMC article.
-
MiR-200a-3p promoted the malignant behaviors of ovarian cancer cells through regulating PCDH9.Onco Targets Ther. 2019 Oct 8;12:8329-8338. doi: 10.2147/OTT.S220339. eCollection 2019. Onco Targets Ther. 2019. PMID: 31632082 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical